Firms

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

ARCH Venture Partners

• Bitterroot Bio$145M · 2023-06-07
• Bitterroot$145M · 2023
• Jaguar Gene Therapy$139M · 2021-04-13
• Jaguar Gene Therapy$139M · 2021
• bluebird bio$60M · 2012-07-25

GV

• Bitterroot Bio$145M · 2023-06-07
• Bitterroot$145M · 2023
• Schrödinger$110M · 2019-05-19

Khosla Ventures

• Relation$35M · 2024-03-14
• Iora Health$75M · 2016-10-13
• Excelsior Sciences$70M · Unknown date

Alexandria Venture Investments

• Bitterroot Bio$145M · 2023-06-07
• Bitterroot$145M · 2023

Eli Lilly and Company

• Jaguar Gene Therapy$139M · 2021-04-13
• Jaguar Gene Therapy$139M · 2021

SHOW MORE

Investments

$35M2024-03-14	Relation	DCVC, Khosla Ventures, NVentures, Deerfield, Magnetic
$145M2023-06-07	Bitterroot Bio	ARCH Venture Partners, Alexandria Venture Investments, GV, Koch Disruptive Technologies, Deerfield
$145M2023	Bitterroot	ARCH Venture Partners, Alexandria Venture Investments, GV, Koch Disruptive Technologies, Deerfield
$139M2021-04-13	Jaguar Gene Therapy	ARCH Venture Partners, The Goldman Sachs Group, Inc., Eli Lilly and Company, Deerfield
$139M2021	Jaguar Gene Therapy	ARCH Venture Partners, The Goldman Sachs Group, Inc., Eli Lilly and Company, Deerfield
$110M2019-05-19	Schrödinger	The Invus Group, LLC, Laurion Capital Management, Deerfield, GV
$75M2016-10-13	Iora Health	Khosla Ventures, Temasek Holdings (Private) Limited, F-Prime Capital, .406 Ventures, Polaris Partners, Deerfield
$60M2012-07-25	bluebird bio	ARCH Venture Partners, Sanofi Ventures, Forbion, Deerfield, Third Rock Ventures
$70MUnknown date	Excelsior Sciences	Khosla Ventures, Sofinnova Partners, Deerfield

SHOW MORE